trial · primary record
BI 764532
Glioma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Occurrence of dose-limiting toxicity (DLT) during the maximum tolerated dose (MTD) evaluation period |
| Registry ID | NCT05916313 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:39.598Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05916313
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.